MENU

Fox Chase Cancer Center News

No associations between location of the tumor and risk for death or tumor recurrence were found.
October 3, 2019

Location of Retroperitoneal Sarcoma Linked With Additional Organ Removal at Surgery

PHILADELPHIA (October 3, 2019) – No associations between location of the tumor and risk for death or tumor recurrence were found. These data do not change how patients with retroperitoneal sarcomas would be treated, but do provide clinicians with a better understanding of the disease.

The award will provide her with research mentorship for creating clinical trials and opportunities to collaborate at a national level with other investigators.
October 2, 2019

Mantia-Smaldone Receives Three-Year Grant to Investigate Gynecologic Malignancies

PHILADELPHIA (October 2, 2019) – Gina Mantia-Smaldone, MD, has been selected by the Gynecological Oncology Group Foundation and NRG Oncology to receive three years of funding to develop her research capacity and scope as a principal investigator of gynecologic malignancies.

October 1, 2019

Fox Chase Cancer Center Reminds Women to Schedule a Breast Cancer Screening

PHILADELPHIA (October 1, 2019) – October is Breast Cancer Awareness month.

A higher-volume facility to provide patients with more experience, expertise, and access to resources.
September 27, 2019

Studies Find Patients Treated at Higher-Volume Cancer Facilities Tend to Live Longer

PHILADELPHIA (September 27, 2019) – These results underscore the ability of a higher-volume facility to provide patients with more experience, expertise, and access to resources.

It is hoped the novel and collaborative approach among the researchers will lead to a better way to prevent or circumvent melanoma therapy resistance in aging cells.
September 23, 2019

Researcher Receives NCI Grant to Investigate Link Between Cell Aging, Melanoma

PHILADELPHIA (September 23, 2019) – Edna Cukierman, PhD, was awarded the grant from the National Institutes of Health/National Cancer Institute to begin research on better understanding the deterioration of collagen integrity via cellular aging and its role in melanoma metastasis.

The median time to cranial neuropathy was more than seven years, with some patients developing cranial neuropathy more than 10 years later.
September 23, 2019

Radiation-Induced Cranial Neuropathy Occurred Up to 10 Years After Head and Neck Cancer Treatment

PHILADELPHIA (September 23, 2019) – Of the 112 patients examined, 14 percent developed at least one cranial neuropathy. The median time was more than seven years, with some patients developing it more than 10 years later.

Cosmesis was rated as good in 81 percent of trials of conventional excision, 74.6 percent of trials of EBRT, and 97.6 percent of trials of brachytherapy.
September 20, 2019

Cosmetic Satisfaction Similar for Radiation, Surgical Treatments of Non-Melanoma Skin Cancers

PHILADELPHIA (September 20, 2019) – Many of the most common treatment modalities for localized non-melanoma skin cancers resulted in similar cosmetic outcome and local control one year after treatment, according to a new study from researchers at Fox Chase Cancer Center.

September 15, 2019

Patient-Reported Quality of Life May Guide Treatment Decisions for Lower-Risk Prostate Cancer

CHICAGO (September 15, 2019) – New research from Fox Chase Cancer Center may help guide men with prostate cancer in selecting the appropriate type of short course radiation therapy to treat their disease.

Pages

Connect with Fox Chase